Matches in Wikidata for { <http://www.wikidata.org/entity/Q37185481> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q37185481 description "article científic" @default.
- Q37185481 description "article scientifique" @default.
- Q37185481 description "articolo scientifico" @default.
- Q37185481 description "artigo científico" @default.
- Q37185481 description "artículu científicu espublizáu en 2008" @default.
- Q37185481 description "bilimsel makale" @default.
- Q37185481 description "scientific article published on July 2008" @default.
- Q37185481 description "vedecký článok" @default.
- Q37185481 description "vetenskaplig artikel" @default.
- Q37185481 description "videnskabelig artikel" @default.
- Q37185481 description "vědecký článek" @default.
- Q37185481 description "wetenschappelijk artikel" @default.
- Q37185481 description "wissenschaftlicher Artikel" @default.
- Q37185481 description "наукова стаття, опублікована в липні 2008" @default.
- Q37185481 description "научни чланак" @default.
- Q37185481 description "مقالة علمية نشرت في يوليو 2008" @default.
- Q37185481 name "A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients" @default.
- Q37185481 name "A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients" @default.
- Q37185481 name "A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients." @default.
- Q37185481 type Item @default.
- Q37185481 label "A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients" @default.
- Q37185481 label "A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients" @default.
- Q37185481 label "A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients." @default.
- Q37185481 prefLabel "A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients" @default.
- Q37185481 prefLabel "A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients" @default.
- Q37185481 prefLabel "A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients." @default.
- Q37185481 P1433 Q37185481-2E1B6E90-FD06-4526-BBCD-B3A04A652AA5 @default.
- Q37185481 P1476 Q37185481-89D93F4C-02BA-4142-AAAB-6B3CF064FA7F @default.
- Q37185481 P2093 Q37185481-4629FBA8-2917-4334-8280-580A24752C30 @default.
- Q37185481 P2093 Q37185481-93505185-0A60-4B8F-9305-8CC9ABB40E18 @default.
- Q37185481 P2093 Q37185481-DA8F3422-487D-4988-83C4-55DB2AE575B0 @default.
- Q37185481 P275 Q37185481-AF0FBAAD-67F2-41A0-982A-734D0C1DF59D @default.
- Q37185481 P2860 Q37185481-18325E62-5158-466F-9F57-F17DEFD36D57 @default.
- Q37185481 P2860 Q37185481-5DC99942-0DAD-4581-AFE0-A59A0A7A2A07 @default.
- Q37185481 P2860 Q37185481-5E5918B6-A609-4DA0-AA6C-842B2357A140 @default.
- Q37185481 P2860 Q37185481-9C875DF7-8E4D-4D87-AF4F-CB50548962A1 @default.
- Q37185481 P2860 Q37185481-9F6C7723-D69A-4969-9CEC-AE2A8FC308E6 @default.
- Q37185481 P2860 Q37185481-A6D53301-3C40-423E-8A10-3EFF5003BBDB @default.
- Q37185481 P2860 Q37185481-A897974E-8AFB-444E-956D-BFB4D3341D31 @default.
- Q37185481 P2860 Q37185481-D813F1E9-85D5-44F6-AAF4-85126F939527 @default.
- Q37185481 P2860 Q37185481-F897EA18-96D6-4380-9F42-B271AD7FAD7A @default.
- Q37185481 P304 Q37185481-FAADA936-1C14-47DF-A817-7B5E05E6B0BC @default.
- Q37185481 P31 Q37185481-BDC1E3AE-6CAE-48BE-8114-88373B821327 @default.
- Q37185481 P356 Q37185481-9CC0062E-B76B-49CB-B822-FCF3E8E4AE84 @default.
- Q37185481 P407 Q37185481-41578C82-115F-4520-8607-0474A1ED90E7 @default.
- Q37185481 P433 Q37185481-5B7FE1DA-90B6-413F-9139-427DDF70DE41 @default.
- Q37185481 P478 Q37185481-17C3C45D-501A-452A-80A3-C6B85C94AEBB @default.
- Q37185481 P577 Q37185481-5A2ED846-A213-47D2-9501-41D50F9603AE @default.
- Q37185481 P6216 Q37185481-6C50A79C-92CC-498E-8DCA-6809EF18A3F2 @default.
- Q37185481 P698 Q37185481-2C3CF86C-A2BE-4FBF-92A0-E32E755CD33A @default.
- Q37185481 P921 Q37185481-2A7E0797-EC85-440A-802D-200F0A079A66 @default.
- Q37185481 P932 Q37185481-EF157E71-2DB3-48F6-9F86-BFEA187D049D @default.
- Q37185481 P356 202464 @default.
- Q37185481 P698 18716688 @default.
- Q37185481 P1433 Q5030529 @default.
- Q37185481 P1476 "A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients" @default.
- Q37185481 P2093 "Delia Vietzke" @default.
- Q37185481 P2093 "Felix Ratjen" @default.
- Q37185481 P2093 "Wilfried H Nikolaizik" @default.
- Q37185481 P275 Q20007257 @default.
- Q37185481 P2860 Q24247996 @default.
- Q37185481 P2860 Q34050120 @default.
- Q37185481 P2860 Q43597188 @default.
- Q37185481 P2860 Q44093085 @default.
- Q37185481 P2860 Q54368501 @default.
- Q37185481 P2860 Q54393152 @default.
- Q37185481 P2860 Q68060128 @default.
- Q37185481 P2860 Q69438135 @default.
- Q37185481 P2860 Q77760906 @default.
- Q37185481 P304 "259-262" @default.
- Q37185481 P31 Q13442814 @default.
- Q37185481 P356 "10.1155/2008/202464" @default.
- Q37185481 P407 Q1860 @default.
- Q37185481 P433 "5" @default.
- Q37185481 P478 "15" @default.
- Q37185481 P577 "2008-07-01T00:00:00Z" @default.
- Q37185481 P6216 Q50423863 @default.
- Q37185481 P698 "18716688" @default.
- Q37185481 P921 Q178194 @default.
- Q37185481 P932 "2679548" @default.